Retropupillary Iris Fixation of an Artisan Myopia Lens for Intraocular Lens Dislocation and Aphakia in Eyes with Extremely High Myopia: A Case Series and a Literature Review

Introduction To describe the outcomes of retropupillary iris fixation of an iris claw Artisan Myopia intraocular lens (IOL), and to review literature on retropupillary iris fixation of iris claw models for myopia for the correction of aphakia and IOL dislocation in eyes with extremely high myopia. Methods Single-center, retrospective case series. Three patients (three eyes) with pathological myopia underwent retropupillary iris fixation of the iris claw Artisan Myopia model 204 for the correction of aphakia and IOL dislocation. After IOL power calculation, we found that the Artisan Aphakia IOL was not available for these patients. One patient had a history of previous extracapsular cataract extraction and two patients exhibited IOL-bag complex dislocation. The target lens power was calculated using ultrasound biometry and the Sanders-Retzlaff-Kraff theoretical and T2 formulae, with an A-constant of 103.8. All surgeries were performed by a single surgeon. Visual outcomes were assessed at 12-48 months after surgery. Results The mean axial length was 34.33 +/- 0.21 mm. The power of the implanted Artisan IOLs ranged between - 4.00 and - 3.00 diopter. The corrected distance visual acuity, measured in logarithm of the minimum angle of resolution units, improved after surgery in all eyes, from 0.60 +/- 0.36 logMAR before surgery to 0.40 +/- 0.43 logMAR after surgery at 12 months postoperatively and remained stationary thereafter. There were no postoperative complications. Conclusions Retropupillary iris fixation of Artisan Myopia IOLs may be a safe and effective surgical treatment option for the correction of aphakia and IOL dislocation in patients with extremely high myopia.

Automated summary

Retropupillary iris fixation of Artisan Myopia IOLs appears to be a safe and effective surgical treatment option for correcting aphakia and IOL dislocation in patients with extremely high myopia, with no significant postoperative complications.